We evaluated responses to empagliflozin and dapagliflozin in an established T2D mouse model where excessive CaMKII activation is known to contribute to myocardial dysfunction and enhanced inducibility of AF (8). This evidence concerns the gene CAMK2G and atrial fibrillation.